Table 1 Patient demographics for blastocyst cryopreserved SET cycles supported with IMP versus 8% Crinone vaginal gel
IMP (n = 1594) | Crinone (n = 116) | |
|---|---|---|
Oocyte age at cryopreservation (y) | 33.9 ± 4.1 | 34.2 ± 3.9 |
Age of recipient at transfer (y) | 35.6 ± 4.2 | 35.6 ± 4.0 |
Gravidity | ||
0 | 671 (42.1) | 52 (44.8) |
≥ 1 | 923 (57.9) | 64 (55.2) |
Parity | ||
0 | 1001 (62.8) | 74 (63.8) |
≥ 1 | 593 (37.2) | 42 (36.2) |
Prior SAB | ||
Yes | 1137 (71.3) | 88 (75.9) |
No | 457 (28.7) | 28 (24.1) |
BMI of embryo recipient (kg/m2) | 25.3 ± 6.0 | 25.4 ± 5.7 |
No. obese recipients a | 257 (16.1) | 12 (10.3) |
Primary infertility diagnosis | ||
Unexplained | 446 (28.0) | 46 (39.7) |
Male factor | 385 (24.2) | 25 (21.6) |
Tubal factor | 85 (5.3) | 5 (4.3) |
Anovulation | 195 (12.2) | 13 (11.2) |
Endometriosis | 72 (4.5) | 6 (5.2) |
Diminished ovarian reserve | 168 (10.5) | 4 (3.5) |
Uterine factorb | 34 (2.1) | 0 (0.0) |
Gestational carrier | 19 (1.2) | 0 (0.0) |
Other | 190 (11.9) | 17 (14.7) |